Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD
2 other identifiers
interventional
15
1 country
1
Brief Summary
The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2024
CompletedFirst Posted
Study publicly available on registry
July 5, 2024
CompletedStudy Start
First participant enrolled
July 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2025
CompletedResults Posted
Study results publicly available
August 27, 2025
CompletedAugust 27, 2025
August 1, 2025
11 months
June 28, 2024
July 29, 2025
August 25, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility, as Measured by the Percentage of Caregivers Who Enroll in the Study
Feasibility was measured by the percentage of caregivers who enrolled in the study out of all eligible participants.
Recruitment (7 months)
Feasibility, as Measured by the Percentage of Tele-visits Conducted
Feasibility was measured by dividing the number of tele-visits conducted by the number of tele-visits that could have been conducted, then multiplying by 100. This measure shows the adherence of the intervention arm to the tele-visits. The percentage is calculated for the group rather than the individual patient.
At the end of the intervention or at 12 weeks, whichever is earlier
Secondary Outcomes (5)
Change in Behavioral and Psychosocial Symptoms of Dementia (BPSD) in the Patient, as Measured by the Neuropsychiatric Inventory Questionnaire
Baseline, 2, 4, 6, 8, 10, 12 weeks
Mean Caregiver Depression Score, as Measured by Patient Health Questionnaire-8
Baseline, 2, 4, 6, 8, 10, 12 week
Mean Caregiver Anxiety Score, as Measured by General Anxiety Disorder-7
Baseline, 2, 4, 6, 8, 10, 12 weeks
Mean Caregiver Burden Score, as Measured by the Zarit Burden Interview - Short Version
Baseline, 2, 4, 6, 8, 10, 12 weeks
Mean Caregiver Perception of Patient's Pain Score, as Measured by the Doloplus 2 Scale Behavioral Assessment
Baseline, 2, 4, 6, 8, 10, 12 weeks
Study Arms (1)
Intervention (I-HoME)
EXPERIMENTALParticipants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs.
Interventions
Video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old and \< 100 years
- English speaking
- Providing care to an ADRD patient who is age ≥ 65 years old and \< 105 years who is a stage 7a-f on the Functional Assessment Staging Tool (FAST) scale
You may not qualify if:
- Non-English speaking
- \<18 years old or \>100 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medicine
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Veerawat Phongtankuel
- Organization
- Weill Cornell Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Veerawat Phongtankuel, MD
Weill Medical College of Cornell University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2024
First Posted
July 5, 2024
Study Start
July 10, 2024
Primary Completion
May 23, 2025
Study Completion
May 23, 2025
Last Updated
August 27, 2025
Results First Posted
August 27, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share